Biopsy and Mutation Detection Strategies in Non-Small Cell Lung Cancer

@inproceedings{Jung2013BiopsyAM,
  title={Biopsy and Mutation Detection Strategies in Non-Small Cell Lung Cancer},
  author={Chi Young Jung},
  booktitle={Tuberculosis and respiratory diseases},
  year={2013}
}
  • Chi Young Jung
  • Published in
    Tuberculosis and respiratory…
    2013
  • Medicine
  • The emergence of new therapeutic agents for non-small cell lung cancer (NSCLC) implies that histologic subtyping and molecular predictive testing are now essential for therapeutic decisions. Histologic subtype predicts the efficacy and toxicity of some treatment agents, as do genetic alterations, which can be important predictive factors in treatment selection. Molecular markers, such as epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) rearrangement, are the… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 10 CITATIONS

    Current and future molecular diagnostics in non-small-cell lung cancer.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 35 REFERENCES